In this article, we will list the 5 best stocks to buy right now according to AI. Please visit 10 Best Stocks to Buy Right Now According to AI if you would like to see the extended list and the methodology behind it.

5. Palantir Technologies Inc. (NASDAQ:PLTR)

Palantir Technologies Inc. (NASDAQ:PLTR) is a specialized software company that builds and deploys advanced data analytics and artificial intelligence platforms for government agencies and commercial enterprises. The company’s core offerings include Palantir Gotham, designed for defense and intelligence sectors to identify patterns within disconnected datasets, and Palantir Foundry, which provides commercial corporations with a central operating system for institutional data. To capture the massive wave of enterprise AI demand, the company launched the Palantir Artificial Intelligence Platform (AIP), allowing organizations to bind large language models directly to their private networks and operational workflows safely.

Palantir Technologies Inc. (NASDAQ:PLTR) business model centers on deep customer integration, using intensive bootcamps to demonstrate immediate operational value. The firm had an outstanding Q1 2026 earnings report. It delivered total quarterly revenue of $1.633 billion, surpassing Wall Street expectations of $1.54 billion and demonstrating strong growth at scale. Diluted earnings per share came in at $0.33, beating consensus estimates of $0.27 by over 22% and representing a massive increase from the $0.13 recorded in the prior-year period. This profitability expansion is driven by the rapid, widespread adoption of its AIP platform within the domestic commercial sector, where corporate customers are leveraging Palantir’s software to deploy operational AI agents.

4. Eli Lilly and Company (NYSE:LLY)

Eli Lilly and Company (NYSE:LLY) is a premier global pharmaceutical corporation dedicated to discovering, developing, and manufacturing innovative human medicines across multiple therapeutic areas. The company’s primary growth catalyst is its world-class cardiometabolic health portfolio, led by the highly successful tirzepatide molecule, marketed as Mounjaro for type 2 diabetes and Zepbound for chronic weight management. Eli Lilly also maintains a prominent market presence in oncology with Jaypirca, immunology with Omvoh and Ebglyss, and neuroscience with Kisunla, an advanced treatment targeting Alzheimer’s disease.

Eli Lilly and Company (NYSE:LLY) relies on heavy reinvestment into clinical research and development, combined with expansion of global manufacturing capacity. The firm recently posted the Q1 2026 financial report that recorded total revenue of $19.8 billion, representing a 56% year-over-year increase, fueled almost entirely by the demand for Mounjaro and Zepbound, which collectively brought in $12.8 billion. Non-GAAP diluted earnings per share skyrocketed by 156% year-over-year to $8.55, vastly exceeding analyst forecasts of $6.97. Eli Lilly maintained a superb gross margin of 82.6%, while its non-GAAP performance margin expanded by 7 percentage points to 50%. Backed by this commercial momentum, management raised its full-year 2026 revenue guidance to $82 billion to $85 billion.

3. NVIDIA Corporation (NASDAQ:NVDA) 

NVIDIA Corporation (NASDAQ:NVDA) is the pioneer of accelerated computing and the primary hardware architectural foundation for the global artificial intelligence revolution. Originally famous for inventing the Graphics Processing Unit (GPU) to revolutionize gaming graphics, the company has transformed into a full-stack accelerated computing enterprise. NVIDIA’s Data Center segment designs and deploys ultra-high-performance AI computing architectures, combining cutting-edge GPUs with proprietary NVLink interconnect networks and the specialized CUDA software ecosystem.

NVIDIA Corporation (NASDAQ:NVDA) recently released Q1 2026 earnings which completely shattered all market expectations. It reported a record-breaking quarterly revenue of $81.62 billion, marking an 85% increase from the $44.01 billion recorded in the same period last year. Net income surged to $58.32 billion, yielding a diluted EPS of $2.39. This unprecedented surge was spearheaded by its Data Center division, which posted a record $75.2 billion in revenue, growing 92% year-over-year as global tech giants execute a collective $750 billion infrastructure buildout. NVIDIA’s gross margins and net profitability remain unmatched.

2. Broadcom Inc. (NASDAQ:AVGO) 

Broadcom Inc. (NASDAQ:AVGO) is a diversified technology leader that designs, develops, and supplies a broad range of semiconductor and infrastructure software solutions. The company’s semiconductor division focuses on complex digital and mixed-signal complementary silicon devices, holding dominant market positions in wireless communications, data center networking, and custom application-specific integrated circuits (ASICs), which Broadcom categorizes as custom XPUs. Broadcom’s infrastructure software business, significantly strengthened by its acquisition of VMware, provides enterprise clients with critical virtualization, cybersecurity, and cloud management platforms.

Broadcom Inc. (NASDAQ:AVGO) had a stellar fiscal Q1 2026 earnings report. Total revenue reached a record $19.3 billion, up 29% year-over-year, driven by a 106% explosion in AI semiconductor revenue to $8.4 billion. The firm posted an adjusted EBITDA of $13.1 billion, or 68% of revenue, alongside a consolidated operating margin of 66.4%. Investors are highly enthusiastic about Broadcom’s $73 billion AI backlog and its multi-year custom silicon partnerships with hyperscalers like Google and Meta. Management provided guidance for Q2 2026, forecasting revenue to climb to $22 billion, representing 47% year-over-year growth, with AI semiconductor sales accelerating to $10.7 billion.

1. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) 

Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is the world’s largest dedicated pure-play semiconductor foundry, serving as the essential manufacturing backbone for the global technology industry. Operating an advanced manufacturing model, TSMC does not design or market its own branded chips; instead, it manufactures semiconductors for the world’s leading technology and chip design firms, including Apple, NVIDIA, AMD, and Broadcom. The company commands an absolute monopoly in leading-edge process nodes, specifically its 3-nanometer and 5-nanometer technologies, which are required to build advanced AI accelerators, high-performance computing systems, and smartphone processors.

Financially, Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is undeniably strong, especially based on its record-breaking Q1 2026 earnings presentation. In the first three months of the year, the chip giant reported consolidated quarterly revenue of $35.9 billion, representing a 40.6% year-over-year increase, with 3nm and 5nm technologies accounting for 61% of total wafer revenues. TSMC’s elite pricing power was evident as gross margins reached 66.2%, prompting management to revise its long-term gross margin target upward to 56% and above through the market cycle. Driven by booming demand for AI accelerators, Taiwan Semiconductor Manufacturing raised its full-year 2026 revenue growth guidance to above 30% in US dollar terms.

READ NEXT: Growth Stock Portfolio: 12 Stock Picks by Carl C. Icahn and Chris Rokos Stock Portfolio: Top 10 Stock Picks.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.